At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
embrace devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Scar Prevention and the Clinical Effectiveness of a Novel Mechanomodulating Polymer
In Brief
A clinical study evaluating embrace device for Hypertrophic. Completed, enrolled 67 participants across 13 sites.
Detailed Summary
Neodyne has developed an investigational dressing for post-operative incision care. Neodyne is conducting this research to study whether the investigational dressing, called the Neodyne Dressing, can minimize scar formation in a simple manner.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertrophic
CountriesUnited States
CollaboratorsU.S. Army Medical Research and Development Command
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedJul 2011
Primary CompletionSep 2012
Study CompletionMar 2013
TodayJul 2026
First PostedJul 21, 2011
Enrollment StartJun 1, 2011
Primary CompletionSep 1, 2012
Study CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.9 years ago
Interventions
embrace devicedevice
Adhesive bandage/dressing intended to minimize scar formation.